Horizon Kinetics Asset Management LLC Sells 8,666 Shares of Royalty Pharma plc (NASDAQ:RPRX)

Horizon Kinetics Asset Management LLC reduced its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Get Rating) by 2.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 399,880 shares of the biopharmaceutical company’s stock after selling 8,666 shares during the period. Horizon […]

Related Keywords

United States ,Roryb Riggs ,Marshall Urist ,Exchange Commission ,Morgan Stanley ,Ci Investments Inc ,Nasdaq ,Mendota Financial Group ,Hikari Tsushin Inc ,Horizon Kinetics Asset Management ,Royalty Pharma ,Get Rating ,Kinetics Asset Management ,Financial Advisors ,Financial Group ,Hikari Tsushin ,Director Rory ,Royalty Pharma Daily ,Nasdaq Rprx ,Rprx ,Finance ,76028h20 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,